Trials / Completed
CompletedNCT05824026
Investigation of the Clinical Performance of Biatain Fiber Ag on Burns
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Coloplast A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to test a new gelling fiber wound dressing with silver on patients with a partial thickness burn wound, which is infected or at risk of infection. Participants will be asked to wear the test dressing in a two weeks period(+/- 2 days) consisting of 3-4 study visits, and will have the dressing changed once pr. week at the research facility. The wound will be cleaned, assessed and photos will be uploaded to a digital software system.
Detailed description
The clinical investigation is a non-comparative, one-armed, open-labelled, multi-centre study. The test product, Biatain Fiber Ag is a non-CE-marked gelling fiber wound dressing, containing silver. The product is intended for moist wound healing and exudate management of moderate to high exuding wounds. The product has a classification III, as it contains the active ingredient silver. The overall purpose of this investigation is to obtain clinical data supporting effectiveness of Biatain Fiber Ag to obtain the CE-mark in EU. The total study duration for the subject will be approximately two weeks (+/- 2 days), consisting of a two-week test period and 4 study visits (V0/V1, V2 and V3). V3 will also terminate the 2-week study period. The primary endpoint is percentage of wounds healed within 14 days (≥ 95 % reepithelialisation) The clinical investigation will be conducted in a total of 50 eligible subjects with a partial thickness burn wound that are infected or at risk of infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Gelling fiber wound dressing with silver | intervention involving a wound dressing with silver |
Timeline
- Start date
- 2023-10-27
- Primary completion
- 2024-04-26
- Completion
- 2024-04-26
- First posted
- 2023-04-21
- Last updated
- 2025-09-11
- Results posted
- 2025-09-11
Locations
5 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05824026. Inclusion in this directory is not an endorsement.